Apollo Hospitals Enterprise Ltd

Apollo Hospitals Enterprise Ltd

Fortune 500 2024
+ 14 More
+ 14 More
OVERVIEW
FINANCIALS
NEWS

About

Dr. Prathap C. Reddy established the Apollo Hospitals in 1983 in Chennai. Since then, it has been a leader in revolutionising private healthcare in India, and Dr. Reddy has been conferred with the Padma Vibhushan for his contributions. A commemorative stamp had been issued by the Government of India to recognise Apollo Hospital’s contributions towards healthcare in India. The Apollo ecosystem includes hospitals, pharmacies, primary care and diagnostic clinics, and retail health models. It also offers health insurance services, telemedicine facilities, medical colleges, a research foundation, and an online consultation portal called ‘ASK Apollo’ along with a home healthcare service. The first proton therapy centre for cancer in Southeast Asia was opened at the Apollo Centre in Chennai. The company has built 73 hospitals, more than 5000 pharmacies, and over 1500 diagnostic centres in cities like Nashik, Guwahati, Rourkela, and Kochi, and more.

Incorporation Year: 1979
Headquarters: Chennai
Top Management: Prathap C Reddy/Dr. Suneeta Reddy
Industry: Healthcare - Ancillary

Featured In Fortune India Ranking

Fortune 500 India
#128(2024)
#138(2023)
#119(2022)
#142(2021)
#129(2020)
#154(2019)
#178(2018)
#178(2017)
#208(2016)
#223(2015)
#242(2014)
#262(2013)
#281(2012)
#284(2011)
#294(2010)
#128(2024)#138(2023)#119(2022)#142(2021)#129(2020)#154(2019)#178(2018)#178(2017)#208(2016)#223(2015)#242(2014)#262(2013)#281(2012)#284(2011)#294(2010)
Ranking Trend Fortune 500 India

Financial Data 2024

Revenue
19,201
(INR Cr)
Net Operating Income
19,059
(INR Cr)
Assets
12,754
(INR Cr)
Profit
899
(INR Cr)
Net Worth
6,928
(INR Cr)

Fortune India Coverage

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS2024202320222021202020192018201720162015201420132012201120102009
Revenue
(INR Cr)
19201
14.8%
16727
10.7%
15108
40.0%
10791
-6.8%
11579
19.1%
9721
16.4%
8354
13.4%
7368
15.7%
6368
22.2%
5210
18.8%
4387
16.8%
3756
19.6%
3140
21.0%
2595
26.0%
2059
25.9%
1635
-
Net Operating Income
(INR Cr)
19059
14.73%
16613
13.30%
14663
38.85%
10560
-6.11%
11247
16.94%
9617
16.67%
8243
13.61%
7256
16.75%
6215
20.01%
5178
18.12%
4384
16.33%
3769
19.74%
3148
20.81%
2605
28.57%
2026
25.54%
1614
32.71%
Profit
(INR Cr)
899
9.7%
819
-22.4%
1056
601.9%
150
-66.9%
455
92.8%
236
101.0%
117
-46.9%
221
-6.5%
236
-30.5%
340
7.3%
317
4.1%
304
38.8%
219
19.3%
184
33.7%
138
34.2%
102
-
Assets
(INR Cr)
12754
10.4%
11557
8.9%
10612
10.8%
9575
1.3%
9451
23.8%
7634
4.7%
7292
2.9%
7087
12.9%
6276
19.7%
5245
20.7%
4346
9.1%
3985
19.2%
3343
8.0%
3095
19.5%
2591
19.6%
2166
-
Net Worth
(INR Cr)
6928
11.9%
6190
10.2%
5616
22.2%
4595
37.9%
3331
0.2%
3326
2.5%
3244
-1.9%
3305
-0.8%
3331
5.0%
3171
6.5%
2977
8.4%
2747
9.6%
2507
32.0%
1899
14.9%
1653
12.6%
1469
13.1%
Employee Cost
(INR Cr)
2494
14.6%
2177
21.8%
1787
11.6%
1601
-13.6%
1853
15.9%
1598
13.8%
1404
17.4%
1197
16.9%
1024
19.0%
860
18.2%
727
16.7%
623
23.9%
503
21.1%
415
27.8%
325
33.3%
244
-
Interest Cost
(INR Cr)
44938137944953332729525718011811910389786046
Cash & Bank Balance
(INR Cr)
93477692472446734741752537937727432023717831288
Total Debt
(INR Cr)
533343324068416035963673342731252834199213441213817957913671

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS2024202320222021202020192018201720162015201420132012201120102009
Profit As % Of Revenues 4.7%4.9%7.0%1.4%3.9%2.4%1.4%3.0%3.7%6.5%7.2%8.1%7.0%7.1%6.7%6.3%
Profit As % Of Assets 7.1%7.1%10.0%1.6%4.8%3.1%1.6%3.1%3.8%6.5%7.3%7.6%6.6%5.9%5.3%4.7%
Profit As % Of Networth 13.0%13.2%18.8%3.3%13.7%7.1%3.6%6.7%7.1%10.7%10.6%11.1%8.8%9.7%8.3%7.0%
Interest Cost to EBITDA % 18.8%18.6%17.3%39.5%33.6%30.7%37.2%35.3%25.6%16.0%17.8%17.0%17.4%18.6%20.0%20.6%
Debt to Equity Ratio 0.770.700.720.911.081.101.060.950.850.630.450.440.330.500.550.46
RONW 14.0%15.0%17.3%2.4%9.2%6.1%1.8%4.0%7.2%10.6%10.6%11.1%9.5%9.7%8.2%6.0%
ROCE 15.4%14.2%16.7%6.5%11.9%9.6%6.6%7.3%9.0%12.1%12.7%13.7%12.9%11.9%10.8%8.9%